Device - Nebuclear Md Hand-held Rubber Bulb Nebulizer

For adults and children 12 years of age and older, the standard dosage for the temporary relief of asthma symptoms is as follows:

• Nebulization: Add 0.5 mL (approximately 10 drops) of racepinephrine inhalation solution (2.25%) to the nebulizer reservoir. If the specific product instructions require dilution, add the specified amount of sterile saline.
• Frequency: The dose may be administered every 3 to 4 hours as needed.
• Maximum Dose: Do not exceed 6 doses in a 24-hour period unless directed by a physician.

• Children 12 years and older: Follow the adult dosing guidelines mentioned above.
• Children under 12 years: The safety and efficacy of over-the-counter racepinephrine have not been established for children under 12. Use in this age group should only occur under the direct guidance of a pediatrician or in an emergency clinical setting for conditions like croup.

Renal Impairment

There are no specific dosage adjustments provided by the manufacturer for patients with kidney disease. However, because metabolites are excreted renally, healthcare providers should monitor these patients closely for systemic side effects.

Hepatic Impairment

Since racepinephrine is metabolized by COMT and MAO in the liver and other tissues, severe liver disease may theoretically slow the clearance of the drug, though this is rarely clinically significant given the short half-life.

Elderly Patients

Patients over the age of 65 may be more sensitive to the cardiovascular effects of racepinephrine. Lower initial doses or less frequent administration may be advisable, and close monitoring of heart rate and blood pressure is essential.

Proper administration is vital to ensure the medication reaches the lungs effectively:

1. 1Prepare the Device: Ensure your nebulizer or atomizer (such as the EZ Breathe Atomizer) is clean and functioning correctly.
2. 2Measure the Dose: Use the provided dropper or unit-dose vial to place the exact amount of medication into the nebulizer cup.
3. 3Breathe Correctly: Place the mouthpiece in your mouth or use a face mask. Breathe deeply and slowly until the mist stops forming (usually 5 to 15 minutes).
4. 4Rinse: After use, it is often recommended to rinse your mouth with water to prevent dryness, though this is more critical with steroid inhalers.
5. 5Storage: Store the medication at room temperature, away from direct light. If the solution turns brown or cloudy, discard it immediately as this indicates oxidation and loss of potency.

Racepinephrine is typically used on an "as-needed" basis. If you miss a dose and you are no longer experiencing symptoms, skip the dose. If you still have symptoms, take the dose as soon as you remember. Do not double the dose to make up for a missed one, as this increases the risk of cardiovascular side effects.

An overdose of racepinephrine can be life-threatening due to its effects on the heart and blood pressure.

• Signs of Overdose: Rapid or irregular heartbeat, severe headache, tremors, chest pain, nausea, vomiting, and extremely high blood pressure.
• Emergency Measures: If an overdose is suspected, seek immediate medical attention or call a poison control center. Treatment usually involves supportive care and the administration of beta-blockers under strict medical supervision to counteract the adrenergic effects.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Overuse of this medication can lead to a decrease in effectiveness and increased risk of serious heart problems.

Because racepinephrine stimulates the sympathetic nervous system, side effects are common even at therapeutic doses. These often feel like an "adrenaline rush."

• Tremor: Involuntary shaking, particularly in the hands. This is caused by the stimulation of beta-2 receptors in the skeletal muscles.
• Nervousness and Anxiety: A feeling of being "on edge" or jittery.
• Tachycardia: A rapid heartbeat that the patient may feel in their chest.
• Palpitations: The sensation that the heart is skipping a beat or pounding.
• Insomnia: Difficulty falling or staying asleep, especially if the medication is used late in the evening.

• Headache: Often described as a throbbing sensation, potentially linked to changes in blood pressure.
• Dizziness: A feeling of lightheadedness or unsteadiness.
• Nausea: Mild upset stomach following inhalation.
• Sweating: Increased perspiration (diaphoresis) due to generalized sympathetic activation.
• Dry Mouth: A decrease in saliva production, leading to throat irritation.

• Arrhythmia: Irregular heart rhythms that may require medical intervention.
• Hypertension: A significant and sudden increase in blood pressure.
• Urinary Retention: Difficulty passing urine, particularly in men with enlarged prostates.
• Muscle Weakness: Paradoxical weakness following the initial stimulatory effect.

> Warning: Stop taking Racepinephrine and call your doctor immediately if you experience any of these.

• Chest Pain (Angina): This may indicate that the heart is not getting enough oxygen due to the increased workload caused by the drug.
• Severe Palpitations: A heart rate that feels dangerously fast or completely irregular.
• Seizures: Though rare, excessive systemic absorption can trigger neurological events.
• Difficulty Breathing: If your breathing symptoms get worse after using the medication (paradoxical bronchospasm), stop use immediately.
• Signs of a Stroke: Sudden numbness, severe headache, or vision changes, which can occur if the drug causes a spike in blood pressure.

Racepinephrine is not intended for long-term, daily use. Prolonged use can lead to:

• Tolerance: The medication may become less effective over time, requiring higher doses to achieve the same bronchodilation. This is dangerous as it increases the risk of side effects.
• Rebound Bronchospasm: When the medication wears off, the airways may become more constricted than they were before the treatment.
• Cardiac Stress: Chronic stimulation of the heart can lead to the development or worsening of underlying heart conditions.

Currently, there are no FDA black box warnings specifically for racepinephrine. However, the FDA requires a specific warning for all OTC asthma products stating that they should not be used unless a diagnosis of asthma has been confirmed by a physician. Furthermore, if symptoms do not improve within 20 minutes or if they get worse, the patient must seek medical help immediately, as this may indicate a life-threatening asthma attack (status asthmaticus).

Report any unusual symptoms to your healthcare provider. Using a diary to track how often you use your rescue medication can help your doctor determine if your asthma is well-controlled.

Racepinephrine is a potent stimulant and must be used with extreme caution. It is only intended for the temporary relief of mild asthma symptoms. If you find yourself needing this medication more than twice a week, your asthma is not well-controlled, and you must see a doctor to discuss a long-term management plan. Excessive use of bronchodilators has been associated with an increased risk of death from asthma.

No FDA black box warnings for Racepinephrine. However, the standard "Asthma Warning" applies: Do not use this product unless a doctor has diagnosed you with asthma. Do not use if you are currently taking a prescription drug for asthma unless directed by your doctor.

• Cardiovascular Disease: Racepinephrine can increase heart rate and blood pressure. It should be used with extreme caution in patients with a history of heart disease, high blood pressure (hypertension), or heart rhythm disorders.
• Diabetes: Adrenergic agonists can increase blood glucose levels by stimulating the breakdown of glycogen in the liver. Diabetic patients should monitor their blood sugar closely.
• Thyroid Disease: Patients with hyperthyroidism (overactive thyroid) are more sensitive to the effects of epinephrine and may experience severe tachycardia or tremors.
• Glaucoma: Racepinephrine can increase intraocular pressure and should be avoided in patients with narrow-angle glaucoma.
• Prostate Enlargement: The drug can cause urinary retention, making it difficult for men with an enlarged prostate to urinate.

Patients using racepinephrine should have the following monitored by their healthcare provider:

• Blood Pressure and Heart Rate: Regular checks to ensure the drug is not causing significant cardiovascular strain.
• Lung Function: Periodic peak flow meter tests or spirometry to assess the underlying severity of the asthma.
• Frequency of Use: Tracking how many doses are used per week to identify worsening asthma control.

While racepinephrine does not typically cause drowsiness, it can cause tremors, nervousness, and dizziness. If you experience these side effects, do not drive or operate heavy machinery until you feel steady and alert.

Alcohol should be avoided or limited while using racepinephrine. Alcohol can increase the risk of cardiovascular side effects and may interfere with the body's ability to respond to respiratory distress.

There is no specific tapering requirement for racepinephrine because it is used as needed. However, if you stop using it and your asthma symptoms return or worsen, you must contact your healthcare provider immediately to transition to a different therapy.

> Important: Discuss all your medical conditions with your healthcare provider before starting Racepinephrine. Never use this medication to treat a severe, life-threatening asthma attack at home; go to the nearest emergency room.

• Monoamine Oxidase Inhibitors (MAOIs): Do not use racepinephrine if you are currently taking an MAOI (e.g., phenelzine, tranylcypromine) or have taken one within the last 14 days. MAOIs inhibit the breakdown of epinephrine, leading to a massive accumulation of the drug in the system. This can result in a "hypertensive crisis," a sudden and life-threatening spike in blood pressure that can cause stroke or heart attack.

• Tricyclic Antidepressants (TCAs): Drugs like amitriptyline or nortriptyline can potentiate the cardiovascular effects of racepinephrine, increasing the risk of arrhythmias and severe hypertension.
• Beta-Blockers: Non-selective beta-blockers (like propranolol) can block the bronchodilating effects of racepinephrine, making it ineffective. Furthermore, they can lead to unopposed alpha-adrenergic stimulation, causing severe high blood pressure.
• Other Stimulants: Taking racepinephrine with other stimulants (e.g., ADHD medications like methylphenidate or diet pills) can lead to excessive heart rate and blood pressure increases.

• Digoxin: Racepinephrine can increase the sensitivity of the heart to digoxin, potentially leading to dangerous heart rhythm disturbances.
• Diuretics: Some diuretics can lower potassium levels. When combined with racepinephrine, which can also lower potassium, the risk of hypokalemia (low potassium) and subsequent heart issues increases.

• Caffeine: Avoid excessive consumption of coffee, tea, soda, or chocolate. Caffeine is a stimulant that can worsen the tremors, nervousness, and rapid heart rate caused by racepinephrine.
• High-Fat Meals: While not directly affecting the inhalation of the drug, overall metabolic health is important for asthma management.

• Ephedra (Ma Huang): This herbal supplement contains ephedrine, which acts similarly to racepinephrine. Combining them can lead to dangerous levels of stimulation.
• St. John's Wort: May have minor interactions with how the body handles stimulants.
• Ginseng: Can have stimulatory effects that may compound the nervousness caused by the medication.

Racepinephrine may interfere with certain medical tests:

• Urinary Catecholamines: It can cause false elevations in tests measuring epinephrine or norepinephrine levels.
• Blood Glucose: It may cause transient elevations in blood sugar readings.

For each major interaction, the mechanism usually involves either the additive effect of stimulating the sympathetic nervous system or the inhibition of the enzymes that break the drug down. Management usually involves avoiding the combination or adjusting the dose under strict medical supervision.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. This includes over-the-counter medications and vitamins.

Racepinephrine must NEVER be used in the following circumstances:

• MAOI Use: As mentioned, using an MAOI within the last 14 days is an absolute contraindication due to the risk of a fatal hypertensive crisis.
• Hypersensitivity: If you have had a previous allergic reaction to racepinephrine or any of the ingredients in the solution (such as sulfites in some formulations), you must not use this drug.
• Narrow-Angle Glaucoma: Because racepinephrine can cause pupillary dilation (mydriasis) and increase pressure within the eye, it can trigger an acute glaucoma attack, which is a medical emergency.

These are conditions where the risks may outweigh the benefits, and the drug should only be used if specifically directed by a doctor:

• Pre-existing Heart Disease: Including coronary artery disease, heart failure, or a history of heart attacks.
• Severe Hypertension: Uncontrolled high blood pressure.
• Hyperthyroidism: Due to the extreme sensitivity to adrenergic stimulation.
• Diabetes: Due to the risk of hyperglycemia.
• Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus.

Patients who are allergic to other sympathomimetic amines (such as pseudoephedrine, phenylephrine, or albuterol) should use racepinephrine with caution, as they may experience similar allergic or adverse reactions. Additionally, many racepinephrine solutions contain sulfites as a preservative; patients with a known sulfite allergy should avoid these products as they can cause life-threatening anaphylaxis.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Racepinephrine. Do not assume that because it is available over-the-counter, it is safe for everyone.

Racepinephrine is classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans. Epinephrine can cross the placenta and may cause fetal tachycardia and increased uterine contractions, potentially leading to reduced uterine blood flow. It should be used during pregnancy only if clearly needed and under the advice of an obstetrician. It is not typically used in fertility treatments.

It is not known whether racepinephrine is excreted in human milk. However, many drugs are excreted in breast milk, and there is a potential for serious adverse reactions in nursing infants, such as irritability and rapid heart rate. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

As noted, OTC racepinephrine is not approved for children under the age of 12. In clinical settings, it is used for croup in younger children, but this requires continuous monitoring of heart rate and oxygen levels. In children, the drug can cause significant agitation and behavioral changes.

Elderly patients are at a higher risk for adverse cardiovascular events when using racepinephrine. They are more likely to have underlying heart disease, hypertension, or prostatic hypertrophy. There is also a higher risk of polypharmacy (taking multiple medications), which increases the likelihood of drug interactions. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range.

While racepinephrine is rapidly metabolized by enzymes, the kidneys are responsible for clearing the resulting metabolites. In patients with significant renal impairment (low GFR), these metabolites may linger, though the clinical impact is usually minimal. No specific dose adjustments are standardized, but caution is advised.

Patients with severe hepatic impairment (Child-Pugh Class C) should be monitored for prolonged effects of the drug, as the liver is one of the primary sites for the COMT and MAO enzymes that inactivate the medication.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or are breastfeeding before using this medication.

Racepinephrine is a non-selective sympathomimetic agent. It acts as an agonist at alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors. The primary therapeutic effect in asthma is mediated through the Beta-2 receptors on the bronchial smooth muscle. Activation of these receptors stimulates the Gs-protein-adenylate cyclase-cyclic AMP pathway. The resulting increase in intracellular cAMP inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations, leading to smooth muscle relaxation and bronchodilation.

• Onset of Action: 1 to 5 minutes after inhalation.
• Peak Effect: 5 to 15 minutes.
• Duration: 1 to 2 hours.
• Tolerance: Repeated use can lead to down-regulation of beta-receptors, a phenomenon known as tachyphylaxis, where the drug becomes less effective.

| Parameter | Value |

|---|---|

| Bioavailability | Low (systemic), High (local lung) |

| Protein Binding | Approximately 25% |

| Half-life | 2-3 minutes (plasma) |

| Tmax | 5-10 minutes (inhalation) |

| Metabolism | Hepatic/Tissue (COMT and MAO) |

| Excretion | Renal (95% as metabolites) |

• Molecular Formula: C9H13NO3 (for epinephrine base)
• Molecular Weight: 183.20 g/mol
• Solubility: Soluble in water and dilute acids.
• Structure: A catecholamine consisting of a benzene ring with two hydroxyl groups (catechol) and an ethylamine side chain.

Racepinephrine is classified as a sympathomimetic bronchodilator. It is related to other adrenergic agonists like albuterol and levalbuterol, though those are "selective" for beta-2 receptors, whereas racepinephrine is non-selective, affecting the heart and blood vessels more significantly.